Bio-Rad Laboratories Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bio-Rad Laboratories, Inc. (BIO.B) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-1.84-0.64-3.634.253.81
Depreciation & Amortization0.150.150.140.140.18
Stock Based Compensation0.060.060.060.050.04
Change in Working Capital-0.62-0.43-1.611.141.09
Change in Accounts Receivable0.020.01-0.09-0.02-0.02
Change in Inventory0.01-0.05-0.160.05-0.05
Change in Accounts Payable-0.04-0.05-0.090.070.12
Change in Other Working Capital0.000.00-0.03-0.010.01
Other Operating Activities0.02-0.010.020.01-0.03
Net Cash from Operating Activities0.460.370.190.670.59
Investing Activities
Capital Expenditures-0.17-0.16-0.11-0.13-0.11
Acquisitions0.000.00-0.10-0.13-0.10
Purchases of Investments0.030.17-0.99-0.080.12
Sales/Maturities of Investments-0.020.860.000.770.00
Net Cash from Investing Activities-0.160.02-1.21-0.80-0.07
Financing Activities
Debt Repayment0.000.000.000.000.00
Common Stock Issued0.020.020.020.020.02
Common Stock Repurchased-0.21-0.44-0.23-0.07-0.11
Other Financing Activities-0.03-0.01-0.010.000.00
Net Cash from Financing Activities-0.22-0.430.97-0.06-0.52
Summary
Effect of Forex Changes on Cash0.010.000.00-0.010.00
Net Change in Cash0.09-0.03-0.04-0.200.00
Cash at Beginning of Period0.400.430.470.670.00
Cash at End of Period0.490.400.430.470.00
Free Cash Flow0.290.220.080.540.48
Supplemental Disclosures
Income Taxes Paid0.100.130.160.130.07